Intrinsic Value of S&P & Nasdaq Contact Us

Hepion Pharmaceuticals, Inc. HEPA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$70.00
+145733.3%

Hepion Pharmaceuticals, Inc. (HEPA) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 1 Buy, 2 Hold.

The consensus price target is $70.00, representing an upside of 145733.3% from the current price $0.05.

HEPA Stock — 12-Month Price Forecast

$70.00
▲ +145,733.33% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Hepion Pharmaceuticals, Inc., the price target is $70.00.
The average price target represents a +145,733.33% change from the last price of $0.05.

HEPA Analyst Ratings

Hold
3
Ratings
1 Buy
2 Hold
Based on 3 analysts giving stock ratings to Hepion Pharmaceuticals, Inc. in the past 3 months
Rating breakdown
Buy
1 33%
Hold
2 67%
33%
Buy
1 analysts
67%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message